Clostridioides difficile (C. difficile) vegetative cell (C. difficile)

Clostridioides difficile (formerly Clostridium difficile) is a Gram-positive, anaerobic, spore-forming bacterium that is a leading cause of healthcare-associated diarrhea [CDC, 2023]. The vegetative cells represent the metabolically active, toxin-producing state of the organism, which colonizes the human colon following the disruption of normal gut flora by broad-spectrum antibiotics [Nature Reviews Disease Primers, 2016]. These cells produce two primary exotoxins, TcdA and TcdB, which cause colonic mucosal injury, inflammation, and the characteristic symptoms of C. difficile infection (CDI) [PubMed, 27077694]. Therapeutic intervention focuses on the eradication of vegetative cells using targeted antibiotics such as vancomycin and fidaxomicin [IDSA Guidelines, 2021]. However, a significant clinical challenge remains the inability of these agents to eliminate C. difficile spores, which can germinate into new vegetative cells after treatment ends, leading to recurrent infections [Journal of Clinical Microbiology, 2018]. Effective management often requires a balance between clearing the vegetative infection and preserving the protective commensal microbiota [Lancet Infectious Diseases, 2015].

Other names

Clostridium difficileC. diffC. difficileClostridioides difficileClostridium difficile vegetative cells

Antibacterial agents target vegetative cells through various mechanisms: Vancomycin inhibits cell wall synthesis by binding to the D-alanyl-D-alanine terminus of cell wall precursors [StatPearls, NBK431054]; Fidaxomicin inhibits the sigma subunit of RNA polymerase, disrupting protein synthesis [FDA Label, Fidaxomicin]; Metronidazole causes DNA strand breakage through the formation of reactive intermediates in the anaerobic environment [StatPearls, NBK539728].